09:15

Consultant Business Meeting

09:15


10:00

Trainee Session

Diagnosis and management of large vessel vasculitis 
Professor Neil Basu, Professor of Musculoskeletal Medicine & Vasculitis, Glasgow University

SLE – challenges in clinical practice
Dr Laura McGregor, Consultant Rheumatologist, Glasgow Royal Infirmary

09:15



09:30


09:45



10:00


10:15


10:35

AHP Session

Rheumatoid arthritis and work
Professor Karen Walker-Bone, Professor of Occupational Rheumatology and Director MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Southampton

Other rheumatic and musculoskeletal conditions and work 
Dr Rosemary Hollick, Clinical Senior Lecturer and Honorary Consultant Rheumatologist, University of Aberdeen

Enabling people with musculoskeletal conditions to work 
Professor Karen Walker-Bone, Professor of Occupational Rheumatology and Director MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Southampton

Research in work – MRC/Versus Centre for Arthritis Musculoskeletal Health and Work
Dr Rosemary Hollick, Clinical Senior Lecturer and Honorary Consultant Rheumatologist, University of Aberdeen

Back to the future
Mr Steve Shutts, Chief Executive Officer, ASTRiiD

Q&A All Speakers 

10:45

Coffee Break and Poster Viewing

11:00

From TwinsUK to back pain patients via the microbiome
Professor Frances Williams, Professor of Genomic Epidemiology and Honorary Consultant in Rheumatology, King’s College London

11:35

What is new in lupus and lupus nephritis? 
Professor David Jayne, Professor of Clinical Autoimmunity, Department of Medicine, University of Cambridge and Honorary Consultant, Department of Medicine, Addenbrooke’s Hospital, Cambridge

12:10

Watson Buchanan Lecture: Update on vasculitis    
Professor Raashid Luqmani, Professor of Rheumatology, Consultant Rheumatologist and Clinical Lead (Head of Clinical Department) in Rheumatology, University of Oxford

12:45

Lunch and Poster Viewing

Annual General Meeting (SSR members only)

13:45

SELECT’ing data to inform clinical decisions in RA: An overview of the SELECT-COMPARE study
Professor Peter Taylor, Professor in Rheumatic Diseases and Consultant in Rheumatology, Oxford University Hospital NHS FT
(The speaker’s session has been organised and funded by AbbVie, including payment of the speaker)

14:15



14:30



14:45



15:00

Abstract Session 1

Unmet need in patients with early rheumatoid arthritis - why do some patients do badly despite modern treat-to-target strategies of care? Results from the Scottish Early RA (SERA) inception cohort.
E Clarke, C Wood, A Tindell, K Graham, A McIntosh, F Morton, D Porter

Frailty in rheumatoid arthritis and its relationship with disease activity, hospitalization and mortality: an analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank.
P Hanlon, F Morton, S Siebert, B Jani, J Lewsey, DA McAllister, FS Mair

No differences in foot pain reductions at 12 months for people with early RA between those who received customised versus prefabricated foot orthoses: early results from the FOCOS trial.
GJ Hendry, KS Gallagher, J Godwin, M Steultjens, J Woodburn  

Pain phenotype and its influence on treatment response in a cohort of patients with 
Psoriatic Arthritis.
F Sunzini, K Stefanov, M Arnott, N Aldhemi, S Siebert, C Goodyear, N Basu

15:15

Coffee Break and Poster Viewing

15:30



15:45



16:00




16:15


16:25

Abstract Session 2

Risk of infection in patients with Rheumatoid Arthritis prescribed Methotrexate – results from the Scottish Early RA (SERA) inception cohort.
S Jain, S Tan, F Morton, D Porter

Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs.
Stuart H Ralston, Duncan Porter, Rosemary Hollick, David McAllister, Helen Colhoun, Paul McKeigue and the Public Health Scotland COVID-19 Epidemiology and Research Cell

Immunological effects of COVID-19 vaccination in immunosuppressed patients with immune-mediated inflammatory rheumatic conditions – preliminary results from the OCTAVE study.
S Siebert, J Brock, F Sunzini, A Melville, M Rutherford, A Najm, V Keillor, M Arnott, S Rundell, S Miller, L Stewart, A Gilmour, C Paterson, N Basu, I McInnes, C Goodyear on behalf of the OCTAVE study group

Implementing “fast-track” referral pathway for suspected Giant Cell Arteritis – quality improvement project.
PH Thing, J Brown, T Griffin, B Wolf, J Sznajd

Audit on Giant Cell Arteritis (GCA) Fast Track Clinic in Tayside.
D Subramanian, S Bhat  

16:35

Prize Giving and Close of Meeting